(Q33343234)

26 July 2017

title

Establishment and characterization of the RMG-V cell line from human ovarian clear cell adenocarcinoma (English)

1 reference

clear cell adenocarcinoma

26 July 2017

0 references

1 reference

1 reference

ovarian clear cell adenocarcinoma

inferred from title

1 reference

1

Daisuke Aoki

1 reference

26 July 2017

Nao Suzuki

2

1 reference

26 July 2017

Nobuyuki Susumu

3

1 reference

26 July 2017

Tomomi Noda

4

1 reference

26 July 2017

Atsushi Suzuki

5

1 reference

26 July 2017

Yutaka Tamada

6

1 reference

26 July 2017

Atsushi Higashiguchi

7

1 reference

26 July 2017

Shinji Oie

8

1 reference

26 July 2017

Shiro Nozawa

9

1 reference

26 July 2017

publication date

1 September 2005

1 reference

26 July 2017

1 reference

26 July 2017

volume

18

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

143-146

1 reference

describes a project that uses

26 July 2017

RMG-V

0 references

cites work

A New CA125-like Antigen (CA602) Recognized by Two Monoclonal Antibodies against a Newly Established Ovarian Clear Cell Carcinoma Cell Line (RMG-II)

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2005.TB00004.X

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1749-0774.2005.TB00004.X

Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning--with special reference to the stem cell of the tumor

21 January 2018

1 reference

12 December 2020

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

1 reference

12 December 2020

Establishment and characterization of cell lines derived from serous adenocarcinoma (JHOS-2) and clear cell adenocarcinoma (JHOC-5, JHOC-6) of human ovary.

1 reference

12 December 2020

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

1 reference

12 December 2020

HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells

1 reference

12 December 2020

10.1111/J.1749-0774.2005.TB00004.X

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1000666051

0 references

1 reference